M
Ming Zhao
Researcher at Ningbo University
Publications - 18
Citations - 271
Ming Zhao is an academic researcher from Ningbo University. The author has contributed to research in topics: Cancer & Randomized controlled trial. The author has an hindex of 8, co-authored 17 publications receiving 192 citations. Previous affiliations of Ming Zhao include The University of Nottingham Ningbo China.
Papers
More filters
Journal ArticleDOI
Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials.
Ming Zhao,Jiayi Chen,Yanyan Yuan,Zuquan Zou,Xiaolong Lai,Daud M Rahmani,Fuyan Wang,Yang Xi,Qin Huang,Shizhong Bu +9 more
TL;DR: The results of this meta-analysis suggest that patients with type 2 diabetes treated with DPP4i do not have a higher risk of developing cancers than patients treated with a placebo or other drugs.
Journal ArticleDOI
HMGA2 promotes adipogenesis by activating C/EBPβ-mediated expression of PPARγ.
Yang Xi,Wanjing Shen,Lili Ma,Ming Zhao,Jiachen Zheng,Shizhong Bu,Shinjiro Hino,Mitsuyoshi Nakao,Mitsuyoshi Nakao +8 more
TL;DR: It is demonstrated that high mobility group protein AT-hook 2 is required for C/EBPβ-mediated expression of PPARγ, and thus promotes adipogenic differentiation, and indicates that HMGA2 is an essential constituent of the adipogenic transcription factor network, and therefore its function may be affected during the course of obesity.
Journal ArticleDOI
Prevalence of Pre-Diabetes and Its Associated Risk Factors in Rural Areas of Ningbo, China.
TL;DR: The rural areas in Ningbo had a high prevalence of pre-diabetes, and overweight and obesity, hypertension, and elevated triglycerides were the major risk factors.
Journal ArticleDOI
Novel long non-coding RNA GACAT3 promotes gastric cancer cell proliferation through the IL-6/STAT3 signaling pathway
Wanjing Shen,Yanyan Yuan,Ming Zhao,Jiahui Li,Jin Xu,Guoying Lou,Jiachen Zheng,Shizhong Bu,Junming Guo,Yang Xi +9 more
TL;DR: It is demonstrated that as a downstream target of the IL6/STAT3 signaling, lncRNA GACAT3 promotes gastric cancer cell growth suggesting that GACat3 is an inflammatory response gene and may be served as a valuable potential target for the treatment of Gastric cancer.
Journal ArticleDOI
Obesity-associated digestive cancers: A review of mechanisms and interventions:
TL;DR: Evidence that obesity-related gene mutations, insulin and insulin-like growth factor signaling pathways, chronic inflammation, and altered adipokine levels often function interdependently rather than independently in carcinogenesis is presented.